Process simulation and techno-economic analysis comparing plant-based and microbial fermentation routes for producing sweet proteins such as thaumatin, brazzein, and monellin. Enables industry partners to evaluate cost, scalability, and sustainability trade-offs across alternative biomanufacturing platforms.
This offering provides computer-based techno-economic modelling and life-cycle analysis to compare alternative biomanufacturing routes for producing high-intensity sweet proteins. The research focuses on evaluating whether transgenic plants and plant-seed-based production systems can deliver significant cost and sustainability advantages over microbial fermentation approaches such as engineered yeast or E. coli. By combining process simulation with environmental impact assessment, the work helps companies identify the most economically viable and environmentally responsible pathway for scaling up sweet protein production.
Sweet proteins offer a natural alternative to sugar and high-intensity sweeteners, with sensory studies indicating that small amounts of thaumatin II can replace up to half of the sucrose in a sweetened formulation. The modelling framework supports decision-making for food, beverage, and ingredient companies seeking to evaluate novel production strategies before committing capital.
Modelling capabilities:
Key findings from prior validation:
The modelling methodology has been validated through a published techno-economic analysis of thaumatin II production at 50 MT/yr scale in collaboration with industry partners. Current and planned work extends the framework to additional sweet proteins, plant seed-based production systems, and fermentation-based comparators. Models are being refined with data from industrial collaborators to improve accuracy across a wider range of production scenarios. The approach is ready for application to partner-specific production challenges and can be adapted to evaluate emerging biomanufacturing platforms.
UC Davis is a comprehensive public research university in Northern California, combining a land-grant heritage with an integrated academic health system and a veterinary teaching hospital. Industry engages through co-located clinical and translational facilities in Sacramento, a campus-adjacent research park, pilot-scale food and bioprocessing facilities, and a statewide extension network for field-to-market deployment. Proximity to the Bay Area and California's Central Valley enables rapid collaboration with startups and established enterprises, while corporate relations staff streamline access to faculty, talent, and core labs. Research is supported by competitive federal funding from agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office and venture support programs provide IP management, licensing, and startup formation pathways for industry partnerships.